Introduction
In familial retinoblastoma, young children develop bilateral multifocal tumors of the retina. On the basis of Knudson's statistical analysis of such families it was suggested that these individuals inherited one defective autosomal allele through the germline and that the wild-type allele was lost during retinal development leading to retinoblastoma (Knudson, 1971) . With the molecular cloning of the retinoblastoma susceptibility gene RB, Knudson's prediction was formally proven. Retinoblastoma arises through inactivating mutations in the retinoblastoma gene located on human chromosome 13q, an area in the genome frequently lost in sporadic forms of cancer. RB is also mutated in sporadic retinoblastoma, lung, breast, prostate and bladder cancer (Harbour et al., 1988; Lee et al., 1988; Horowitz et al., 1990; Knudson, 1993; Bookstein, 1994; Miyamoto et al., 1995) . Whereas in inherited retinoblastoma, patients show an increased predisposition to second primary tumors such as osteosarcoma, melanoma and brain tumors (Moll et al., 1997) they are not at higher risk for developing other types of cancer (Eng et al., 1993) . This indicates that in the majority of sporadic cancers RB loss is not the rate-limiting step in the disease.
With the development of methods to manipulate the mouse genome by insertion or targeted deletion of genes it has become possible to study the consequences of gene mutations such as those found in human cancer directly in an experimental model system. These mouse models can provide important insights into the etiology of speci®c cancers and may provide a rational basis for the development of new therapeutic protocols. This review will elaborate on some of the phenotypes in mice carrying genetically modi®ed alleles of the retinoblastoma tumor suppressor gene (Rb).
pRB and growth control
The ®rst indication that the retinoblastoma gene ful®ls a role in suppressing cellular proliferation came from studies using DNA tumor viruses. Studies of SV40 large Tumor antigen (Tag), adenovirus E1A, and the human papilloma virus (HPV) E7 protein have uncovered molecular mechanisms underlying cellular transformation. These viruses enable the immortalization and transformation of a variety of cell types in vitro as well as in vivo. All of these oncoproteins have the capacity to bind to and interfere with the growth suppressing properties of pRB and its family members p107 and p130. The molecular basis for their transforming capacity of cells is in part related to the direct binding of these oncoproteins to the pRB family. Mutants that have lost the capacity to interact with the pRb family have reduced transforming capacity (Christensen and Imperiale, 1995; Zalvide and DeCaprio, 1995) .
The retinoblastoma gene product pRB is a nuclear phosphoprotein that plays a pivotal role in the decision process of a cell to enter or exit the cell cycle (Weinberg, 1995; Grana et al., 1998) . pRB is present throughout the cell cycle, but its phosphorylation state changes in a cell cycle-dependent manner. Quiescent (Go) cells have un-or hypo-phosphorylated pRB. When cells are stimulated to divide they transverse G1 and pRB becomes progressively phosphorylated permitting cells to enter S phase. This phosphorylation is mediated by G1-cyclins and their associated cyclindependent kinases (CDKs), cyclin D-CDK4/6 and cyclin E/A-CDK2 and is thought to inactivate pRB function (Sherr, 1993) . A schematic representation of pRB regulation during the cell cycle is given in Figure  1 .
pRB regulation
The E2F family of transcription factors are among the cellular proteins that bind to unphosphorylated pRB. To date the E2F family of transcription factors comprises of at least six members (E2F1-E2F6). They regulate the expression of genes important for cell cycle progression (Weinberg, 1995) . E2F activity changes in a cell cycle-dependent manner and is controlled by dimerization to regulatory proteins of the DP-family and their association with the retinoblastoma family of pocket proteins (Bernards, 1997; Dyson, 1998) .
Unphosphorylated pRb binds E2F and phosphorylation of pRB results in the release of E2F. Free E2F will stimulate quiescent cells to enter S phase. Viral oncoproteins prevent the binding of pRB to E2F. Speci®c phosphatases remove the inactivating phosphate groups from pRB during the G2-M phase of the cell cycle which again enables the binding of E2F before the cells enter a new cycle. Not only does binding of pRB inhibit the transactivation properties of E2F, the pRB-E2F complex also functions as an active repressor of cellular promoters (Brehm et al., 1998; Magnaghi-Jaulin et al., 1998; Zhang et al., 1999) . Thus, inactivation of pRB by phosphorylation, genetic mutation or by binding to viral oncoproteins abolishes the inhibitory eect on E2Fs which promotes G1-S transition. Consistent with this, overexpression of pRB induces a growth arrest in cells that can be overcome by co-expression of E2F.
Another ). These CKIs are involved in regulating CDK activity throughout the cell cycle by direct binding to cyclin-CDK complexes. The INK4 family of kinases exclusively binds and regulates the cyclin D associated kinases CDK4 and CDK6 (Ruas and Peters, 1998) whereas the CIP/KIP family binds and regulates the activity of cyclins D, E and A in complex with their kinases (reviewed in Sherr and Roberts, 1995) . The p16 CKI (INK4a, CDKN2, MTS1), directly binds and inhibits the CDK4 and CDK6 kinases which results in a decrease of pRB phosphorylation, thus the p16 gene can function as a tumor suppressor. Overexpression of p16 induces a growth arrest in cells that have a functional pRB but not in cells lacking RB, suggesting they act in a linear pathway (Koh et al., 1995; Lukas et al., 1995; Medema et al., 1995) .
The INK4a locus encodes two non-overlapping proteins; p16 and p14 ARF (p19 ARF in the mouse). The p14 ARF gene (hereafter ARF) uses an alternative reading frame of p16 exon 2 but has its own unique exon 1. ARF expression is under control of a promoter upstream of the p16 promoter (Quelle et al., 1995) . Although there is no sequence similarity between ARF and p16, ARF can also arrest cells in the G1-and G2-phase of the cell cycle. Several observations support the notion that ARF regulates a p53-dependent checkpoint. Cells lacking ARF or p53 show an attenuated response to Myc induced apoptosis under low serum conditions , and spontaneously immortalize during in vitro culture. Immortalization of wild-type ®broblasts invariably leads to mutations in either ARF or p53. (Kamijo et al., 1997) . ARF regulates p53 by inhibiting Mdm2 mediated degradation of p53 Pomerantz et al., 1998; Zhang et al., 1998c) . INK4a de®cient cells that lack ARF and p16 also immortalize in culture and are transformed after introduction of oncogenic Ras (Serrano et al., 1997) . Thus it appears that Myc and Ras target two independent but interconnected pathways; the RB pathway and the p53 pathway, linked by a single gene locus INK4a (Bates et al., 1998; . While overexpression of Myc under low serum induces apoptosis and overexpression of Ras senescence, concordant overexpression results in cellular transformation (Sherr, 1998) .
The members of CIP/KIP family p21, p27 and p57 seem to play a broader role in cyclin inhibition as all bind and inhibit CDK2/cyclin A/E kinase activity (Sherr and Roberts, 1995) . Recently it was demonstrated that p21 and p27 CKIs serve a dual role; as inhibitor of cyclin E/CDK2 activity and as an essential assembly factor of cyclin D/CDK4 complex. Cells lacking both p21 and p27 show reduced levels of cyclin D kinase activity after mitogen stimulation (Cheng et al., 1999; Parry et al., 1999) . The p21 gene also has a role in dierentiation that is distinct from its role in suppressing cyclin-CDK activity (Di Cunto et al., 1998) .
The RB pathway in human cancer
The signi®cance of the RB regulatory pathway in normal cells is emphasized by the fact that the majority of human sporadic cancers carry mutations in this pathway aecting either cyclin D, CDK4, INK4a or RB (Figure 1 and Hall and Peters, 1996; Sherr, 1996; Mulligan and Jacks, 1998 In response to mitogenic signals pRB is phosphorylated by cyclin D/CDK complexes which results in the release of pRB bound E2F1 and transcription of S phase genes. Other species of E2F (E2F2-5) bind RB (E2F2 and 3) and the pRB relatives p107 and p130 (E2F4 and 5) and also promote G1 progression. Further phosphorylation of pRB by cyclin E/CDK2 is required for cell cycle progression. Cyclin/CDK activity is regulated by the INK4-and the CIP/KIP family of kinase inhibitors. INK4 CKIs speci®cally inhibit CDK4 and 6 kinase activities, while the CIP/ KIP family inhibit cyclin E/CDK2 complexes but also promote the assembly of cyclin D/CDK complexes. RB loss can result in p53-dependent and -independent apoptosis. p53-dependent apoptosis may require E2F1 and ARF. ARF inhibits Mdm2-mediated degradation of p53. pRB-de®ciency can also lead to p53-independent apoptosis independent of E2F1. Viral oncoproteins; SV40-T antigen, HPV-E7 and Adenovirus E1A bind to, and functionally inactivate pRB family members. SV40-T antigen also sequesters p53 (not indicated). Gene products indicated in bold face have been found mutated in human cancer (see text for details) highlights that p16 within the INK4a locus is the important gene in sporadic cancer and familial melanoma (Ruas and Peters, 1998) . However, it must be noted that the majority of human tumors carry deletions of the INK4a locus also aecting ARF and therefore disabling p53 function via Mdm2 (see above). It is expected that tumors that have intact ARF function will sustain p53 mutations while mutations in the INK4a locus that aect both ARF and p16 will not (Pomerantz et al., 1998) .
The majority of cancers harboring mutations in p16 lack mutations in RB and vice versa suggesting RB and p16 are in a linear pathway, e.g. in glioblastoma either RB or p16 is functionally inactivated (Ueki et al., 1996) . In small cell lung cancer (SCLC) RB loss is observed in almost 100% of the cases but p16 remains wild-type while in non-small lung cancer (NSCLC) RB is wild-type and p16 is invariably lost, indicating that in dierent cell types either RB or p16 might play a more predominant function (Otterson et al., 1994) .
Similarly overexpression of cyclin D1 is seen in breast, thyroid and head and neck cancer and rarely accompanies loss of RB (Hall and Peters, 1996; Zou et al., 1998) . In contrast RB loss accompanies cyclin D ampli®cation in the progression of parathyroid adenoma to carcinoma (Cryns et al., 1994) . CDK4 is found mutated in melanoma (Maelandsmo et al., 1996) . In osteosarcoma mutations in CDK4 may also occur in addition to RB loss (Kanoe et al., 1998) . Therefore, during cancer development individual genes in the RB pathway may have overlapping roles but also distinct functions that confer additional growth advantage to cancer cells already harboring mutations in this pathway.
Tumor predisposition in Rb mutant mice
In humans loss of function of RB is rate limiting for the development of retinoblastoma. In contrast Rb +/7 mice never develop retinoblastoma but primarily thyroid medullary carcinoma (Williams et al., 1994a) and pituitary adenocarcinoma's of the intermediate lobe (Jacks et al., 1992; Hu et al., 1994; RobanusMaandag et al., 1994) . In these tumors the corresponding wild-type allele is lost.
Why do the phenotypes in mouse and man with germline mutations dier so dramatically? Since humans only have a rudimentary intermediate lobe this explains the absence of intermediate lobe tumors in humans, but the lack of retinoblastomas in mice with Rb mutations is not understood. This dierence may be related to species-speci®c dierences in the number of susceptible cells, the timing of susceptibility or a dierence in mutational requirements Hooper, 1998) . The ®nding that chimeric mice generated from ES cells carrying two inactivated copies of Rb do not develop retinoblastoma would argue that contrary to the situation in man, Rb loss in the murine retina is insucient for retinoblastoma development (Robanus-Maandag et al., 1994; Williams et al., 1994b) . This indicates that more mutations may be required for retinoblastoma development in mice. In man there is also evidence that loss of function of RB is not sucient for retinoblastoma development and that more mutations are required (Gallie et al., 1999) .
In man the incidence of unilateral retinoblastoma was found to correlate with the exposure to ultraviolet radiation from sunlight (Hooper, 1999) . Possibly, exposure of the human retina to sunlight causes additional mutations not occurring in laboratory Rb +/7 mice exposed to arti®cial light. In mice there is now strong evidence that in addition to Rb loss, loss of the Rbrelated gene p107 is important in retinoblastoma development (see below) (Robanus-Maandag et al., 1998) .
Germline mutations in RB predispose to a limited spectrum of tumors in man while in sporadic cancer RB loss occurs frequently in a wide range of tumors. Therefore, loss of RB is not necessarily a rate limiting event for tumor initiation but can also provide a growth advantage during later stages of disease. For example, in analysis of breast cancer, RB loss was found in advanced stages of breast cancer but was not seen in benign lesions (Varley et al., 1989; Deng et al., 1996) . This was also illustrated in mice where combined mutations in Rb and p53 led to a broader spectrum of tumors than in either mutant alone and resembling a multiple endocrine neoplasia syndrome (Williams et al., 1994a; Harvey et al., 1995; Coxon et al., 1998) .
What is the molecular explanation for the strong collaboration between Rb and p53 in tumor development in mice? There is increasing evidence now that loss of Rb results in p53-dependent apoptosis in vivo. This comes primarily from the study of transgenic mice expressing SV40-T antigen or HPV-E7 in brain epithelial cells, the retina and in the lens (Howes et al., 1994b; Pan and Griep, 1994; Symonds et al., 1994) . Transgenic mice that express full length T antigen in brain epithelial cells develop choroid plexus tumors. In contrast, expression of a truncated T antigen (TgT 121 ), that is incapable of p53-binding, results in apoptosis which greatly attenuates tumor development in these animals. This apoptosis was p53-dependent since T 121 , p53 7/7 mice apoptosis was completely suppressed and tumors developed with similar latencies as in mice with full length T antigen expression (Symonds et al., 1994) . Recently, it has been elucidated how loss of Rb results in p53-dependent apoptosis. E2F1 appears to play a crucial role. (Pan et al., 1998; Tsai et al., 1998) . TgT 121 , E2F1 7/7 de®cient mice show attenuated apoptosis similar to TgT 121 , p53 7/7 mice. However, this does not lead to an earlier onset of tumor formation most likely due to the simultaneous inhibition of cell proliferation by the absence of E2F1. The delayed onset of pituitary tumors in Rb
7/7 mice also illustrates this . Thus, while loss of E2F1 suppresses p53-dependent apoptosis it also suppresses cell proliferation. These opposing roles of E2F1 in promoting cell growth and inducing p53-dependent apoptosis provide the molecular explanation of how Rb loss in mice results in cell cycle entry followed by p53-dependent apoptosis. The fact that E2F1 functions both as an oncogene (promotes cell growth) and as a tumor suppressor (reduces apoptosis) may at the same time explain why it has not been found mutated in human cancer.
Whereas Rb loss may trigger p53-dependent apoptosis, p53 de®ciency may also indirectly facilitate tumor cell proliferation without aecting apoptosis (Jones et al., 1997) . This is likely a consequence of genome instability in p53-de®cient cells leading to the accumulation of secondary mutations (Harvey et al., 1993b; Bouer et al., 1995; Venkatachalam et al., 1998; 7/7 mutant mice (Williams et al., 1994a) . Remarkably, a retrospective analysis of the p53 status in spontaneous tumors from p53 +/7 mice revealed that a large fraction had retained the p53 wild-type allele suggesting that reduced levels of p53 already have a mutagenic eect in some tissues (Venkatachalam et al., 1998) .
Although pRb, and its relatives p107 and p130 perform overlapping functions during mouse development, inactivation in the germline of neither p107 nor p130 (Cobrink et al., 1996) leads to tumor formation (Mulligan and Jacks, 1998 ). However, one should keep in mind that other factors in the genetic background can aect tumor predisposition in mice and man (Balmain and Nagase, 1998). For example, it has been observed that the genetic background in¯uences tumor predisposition in p53 (Harvey et al., 1993a) as well as in Rb mutant mice . A dramatic illustration of strain-dependent modi®ers of the phenotype of p107 and p130 knockout mice was recently reported. Mice with p107 and p130 loss-of-function mutations on a mixed 129/C57B16 background develop normally (Mulligan and Jacks, 1998 ) whereas on a BALB/cJ background p107 de®ciency results in growth retardation and myeloid hyperplasia (LeCouter et al., 1998a) and p130 de®ciency leads to embryonic lethality (LeCouter et al., 1998b) . It is tempting to speculate that the reduced activity of p16 in BALB/c mice, recently identi®ed as the plasmacytoma susceptibility locus (Pctr1), is responsible for the penetrance of p107 and p130 de®ciencies in mice by reducing the activity of pRb (Zhang et al., 1998b) . While the nature of these modi®er genes in BALB/cJ mice await molecular identi®cation, they are likely also of profound importance for cancer susceptibility in man.
Rb and development
Mice nullizygous for the retinoblastoma gene die at mid-gestation (E12 ± 15) with defects in neurogenesis, fetal liver erythropoiesis and lens development (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992; Morgenbesser et al., 1994) . Analysis of the phenotypes of Rb null mice revealed a defect in proliferation and end-stage dierentiation in several lineage's.
In the central-and peripheral nervous system (CNS and PNS) of mutant embryos massive cell death is particularly evident in the hindbrain and the dorsal root ganglia . In addition, ectopic mitosis is seen in areas in the brain. Rb-de®cient neuronal cells show an intrinsic de®ciency in their response to NGF upon in vitro culture, as measured by their reduced survival and impaired neurite outgrowth . Whereas one would expect that phenotypic aberrations in brains of mutant embryos are cell autonomous the defect is fully rescued in chimeric mice (Robanus-Maandag et al., 1994; Williams et al., 1994b) . This indicates that wild-type cells permit the survival of mutant cells through a paracrine mechanism. Although, Rb-de®cient cells signi®cantly contributed to the brains of these chimeric animals, the in situ identi®cation of Rbde®cient cells will be necessary to determine whether Rb-de®ciency is compatible with the generation of all the cell types in the brain, i.e. Rb-de®ciency in a speci®c subset of cells might be detrimental for neuronal survival and therefore a cell autonomous defect cannot be excluded as yet.
At day E 12.5 livers of Rb 7/7 embryos are smaller and contain enlarged sinusoids, a reduced number of hepatocytes, and an increase in immature nucleated red blood cells. Transplantation of Rb 7/7 fetal liver cells into lethally irradiated recipient mice and the analysis of Rb-de®cient chimeric mice showed that Rb 7/7 cells can contribute to all haematopoietic lineage's Robanus-Maandag et al., 1994; Williams et al., 1994b; Hu et al., 1997) . Furthermore, the analysis of chimeric mice strongly suggested that the erythroid phenotype was non cell autonomous since wild-type and Rb-de®cient cells contributed equally to the erythroid lineage, although a delay in enucleation of both mutant and wild-type cells was observed. Transplantation of Rb 7/7 fetal liver cells into wildtype recipient mice demonstrated a clear defect in erythropoiesis (Hu et al., 1997) . Reconstituted mice were anemic, showing extramedullary erythropoiesis, and an increase in nucleated red blood cells that persisted for more than 6 months. These data raise the possibility that the defect in erythropoiesis in Rb null mice is also due to a defect in a cell of the haematopoietic lineage rather than a defect in hepatocyte function. There is evidence that heterotypic interactions between hematopoietic progenitors in the fetal liver are required for terminal maturation of erythroblasts leading to enucleation (Hanspal and Hanspal, 1994) . Similar interactions between mutant and wild-type cells in chimeric mice may explain a rescue of the enucleation phenotype. Such interactions would also be compromised in mice reconstituted with Rb 7/7 hematopoietic progenitor cells. The generation of mice with erythroid-speci®c Rb disruption could address the importance of Rb on erythroid differentiation.
The lens in mice has provided an excellent experimental system to study the Rb pathway in cellular proliferation and dierentiation. Rb-de®ciency in the lens results in inappropriate proliferation, p53-dependent apoptosis and improper lens ®ber differentiation and elongation (Morgenbesser et al., 1994) . This phenotype is intrinsic to the lens epithelial cells since it is also seen in both Rb-de®cient chimeric mice and mice carrying a hypomorph Rb minigene (Robanus-Maandag et al., 1994; Williams et al., 1994b; Zacksenhaus et al., 1996) (M Vooijs and A Berns, unpublished results). During the process of normal lens ®ber cell dierentiation cyclin/CDK complexes act cooperatively to regulate G1/S transition in the proliferating lens epithelial cells, while in postmitotic lens ®ber cells cyclin/CDK activity is countered by p57
Kip2 and p27 Kip1 CKIs (Zhang et al., 1998a; Gomez Lahoz et al., 1999) . Whereas overexpression of cyclin D/CDK4 alone or in concert with cyclin E/CDK2 promotes S phase in postmitotic lens ®ber cells, expression of cyclin E/CDK2 alone does not. Complete inactivation of pRb by phosphorylation requires sequential kinase activities of D-and E-type cyclins (Lundberg and Weinberg, 1998) . p57 de®ciency in mice results in unscheduled proliferation and apoptosis in the lens (Zhang et al., 1997) . This defect is similar to, but less severe than, the consequences of pRb-de®ciency on the lens. Overexpression of cyclin D/ CDK4, but not cyclin E/CDK2, in p57-de®cient mice resulted in rates of proliferation and apoptosis in the lens equivalent to that seen in Rb 7/7 embryos (Gomez Lahoz et al., 1999) . p27 is normally not required for lens development but contributes signi®cantly to cell cycle arrest and dierentiation in the absence of p57 (Zhang et al., 1998a) . The lenses of p27/p57 double mutants show high levels of proliferation and lack of apoptosis. These results suggest that these CKIs function redundantly in controlling cell cycle arrest and dierentiation of lens ®ber cells via the Rb pathway. In p27/p57 null embryos there is marked reduction in the levels of apoptosis compared to pRbde®cient lenses and similar to that observed in Rb/p53 mutant embryos (Zhang et al., 1998a) . Apoptosis in Rb null lenses is p53-dependent and signals through E2F1 (Tsai et al., 1998) . Therefore, the suppression of apoptosis in p27/p57 mutant mice likely interferes with the pRb-E2F1-p53 pathway. Another dierence between pRb-and p27/p57-de®cient lenses is the higher rate of proliferation in the latter. Possibly, this is related to the capacity of these CKIs to regulate inactivation of the pRb family member's p107 and p130. Mice carrying mutations in p107 and p130 (Cobrinik et al., 1996) do not show any lens defects. Biochemical analysis of lens extracts showed that p107 but not p130 is found in complexes with E2Fs in lens epithelial cells (Rampalli et al., 1998) . Functional overlap between pRb and p107 in lens development can now be studied in chimeric mice carrying cells both mutant for Rb and p107 (RobanusMaandag et al., 1998).
Remarkably, Ink4a 7/7 mice have not been reported to show a lens phenotype (Pomerantz et al., 1998) . Ink4a-de®ciency did suppress apoptosis in Rb 7/7 lenses. This was attributed to the concomitant inactivation of ARF in these mice which functions upstream of p53. The partial rescue from apoptosis in the lenses of embryos indicates that p53 function in this setting is only in part dependent on ARF.
p53-dependent apoptosis in Rb 7/7 embryos or Rb de®cient tumors is mediated by E2F1 (Pan et al., 1998; Tsai et al., 1998) . E2F1 null mice are viable but show tissue atrophy and tumor predisposition (Yamasaki et al., 1996) . Embryos double mutant for Rb and E2F1 show reduced levels of ectopic mitosis and apoptosis in CNS and lens. This illustrates two functions for E2F1 in vivo, to promote proliferation and to facilitate p53-dependent apoptosis. The reduction in apoptosis seen in the CNS and lenses of Rb 7/7 , E2F1 7/7 embryos is similar to that observed in Rb 7/7 , p53 7/7 embryos (Morgenbesser et al., 1994; Macleod et al., 1996) . This indicates that deregulated E2F1 activity is necessary and sucient for p53-mediated apoptosis in these tissues in Rb mutant embryos (Tsai et al., 1998) . It will be interesting to see how the limited apoptosis inhibition seen in INK4a
, Rb 7/7 embryos can be reconciled with the more eective inhibition of apoptosis in the lenses of Rb 7/7 , E2F1 7/7 embryos. Especially, the role of the ARF/Mdm2 pathway, which is directly activated by E2F1 is here of interest (Bates et al., 1998) .
In contrast to the CNS, apoptosis in the PNS of Rb mutant embryos is p53-independent (Macleod et al., 1996) . Furthermore, analysis of Rb 7/7 , E2F1 7/7 mutant embryos indicated that E2F1 mutation only in part reduced apoptosis of Rb-de®cient PNS neurons. Apart from the inactivation of E2F1-mediated transcription by Rb, Rb-E2F1 complexes can also actively repress transcription. Active repression by transduced Rb-E2F1 complexes was shown to be important for p53-independent apoptosis in cells lacking Rb and p53 (Hsieh et al., 1997; Phillips et al., 1997) . In Rb mutant embryos, the absence of active repression may explain p53-independent apoptosis in PNS neurons. The identi®cation of pathways controlling p53-independent apoptosis in Rb mutants is of great interest. Since the embryonic lethality of Rb null mice is only partially rescued by absence of E2F1, pRb has functions beyond E2F1 regulation (Bernards, 1997; Dyson, 1998) .
Due to the longer lifespan of Rb
embryos additional phenotypic aberrations were also observed. Most notably is a defect in myogenesis, as was previously observed in mice carrying a hypomorph Rb allele (Zacksenhaus et al., 1996; Riley et al., 1997) .
A role for pRb in myogenic dierentiation is supported by the observation that Rb-de®cient ®broblasts induced to dierentiate by MyoD are impaired in the expression of late dierentiation markers and unable to maintain the dierentiated phenotype (Schneider et al., 1994; Novitch et al., 1996) . Rb-de®cient ®broblasts also fail to undergo adipocyte dierentiation, which is related to a direct interaction between pRb and the CCAAT/enhancer binding proteins (C/EBP) (Chen et al., 1996) . Altogether, these phenotypic aberrations point to a role for Rb in the initiation of terminal dierentiation of some of these lineage's. Rb-de®cient cells that do not respond to dierentiation signals enter the cell cycle and die by apoptosis. Thus, Rb seems to ful®l three narrowly intertwined roles: (1) to suppress cell cycle entry (2) to promote dierentiation and (3) to inhibit apoptosis.
Mutation analysis has shown that pRb has genetically and mechanistically distinct functions important for promoting growth and dierentiation. For example, Rb mutants defective in E2F1-mediated transcriptional repression and therefore in G1-arrest can retain their ability to activate transcription and promote dierentiation of cells in vitro (Sellers et al., 1998) . Interestingly, similar mutations are found in the human population and are associated with a lowpenetrance form of retinoblastoma (Bremner et al., 1997) .
Retinoblastoma in mice
Rb-de®ciency causes embryonic lethality complicating the study of the role of Rb during later stages of development. Fortunately, the generation of chimeric mice derived from Rb-de®cient cells have provided a number of clues. Surprisingly, Rb 7/7 , Rb +/+ chimeric mice are relatively normal while showing signi®cant contribution of Rb-de®cient cells to most tissues (Robanus-Maandag et al., 1994; Williams et al., 1994b) . However, careful examination of the retina of chimeras has revealed that Rb-de®cient cells are excluded from postnatal retinal dierentiation by apoptosis. Apoptosis of Rb-de®cient cells was evident in both the outer-and the inner nuclear layer of the retina (Robanus-Maandag et al., 1994 . This indicates that Rb is required at speci®c stages of retinal dierentiation. Furthermore, Rb inactivation appears to be insucient for retinoblastoma development in mice illustrating a fundamental dierence in retinoblast behavior between mouse and man.
Nonetheless, there are indications that inactivation of Rb may be important in retinoblastoma formation in mice. Retinal expression of viral oncoproteins in transgenic mice was shown to result in retinoblastoma in several cases (summarized in Table 1 ) (Windle et al., 1990; al-Ubaidi et al., 1992; Howes et al., 1994a,b) . These results suggest a requirement for the inactivation of pRb and other pocket-proteins as well as p53 in the development of these tumors.
Using dierent promoters driving the expression of T antigen, it has become clear that the timing of pRb inactivation is crucial. While postnatal expression of T antigen controlled by the Rodopsin promoter shows p53-dependent apoptotic photoreceptor cell loss in the outer nuclear layer (ONL) of the retina (al-Ubaidi et al., 1992b (al-Ubaidi et al., , 1997 , mice with embryonic expression of T antigen using the Interstitial Retinol Binding Protein (IRBP) promoter develop retinoblastomas (al-Ubaidi et al., 1992a) . Similarly, T antigen expression in postmitotic horizontal cells of the inner nuclear layer (INL) leads to cell death while expression in proliferating amacrine cells leads to growth (Hammang et al., 1993) . These results strongly support the notion that: (1) Rb loss in terminally dierentiating cells leads to cell death while losing Rb in undierentiated precursor cells in the retina leads to tumor formation; (2) that inactivation of p53 or other anti-apoptotic activities of T antigen are not sucient to rescue cell death at this stage of retina development. In addition, early inactivation of pRb and other pocket proteins triggered by IRBP is insucient for tumor outgrowth. This is in accordance with data from IRBP-E7 mice that also show photoreceptor cell death (Howes et al., 1994b) .
Retinoblastomas only developed when these mice were bred to the p53 null background, suggesting a role for p53-dependent apoptosis of Rb-de®cient IRBPexpressing cells in the retina (Howes et al., 1994b) . In human retinoblastoma apoptosis is well documented, albeit there is no evidence for the involvement of p53 mutation (Hamel et al., 1993; Ito et al., 1994; Gallie et al., 1999) . Interestingly, retinoblastoma cell lines are susceptible to p53-induced apoptosis (Nork et al., 1997) . Retinoblastoma development in T antigen transgenic mice is also in¯uenced by genetic background. Retinoblastomas occurred at high frequency in a mixed (C57Bl/66FVB) background while tumor formation was considerably suppressed in the FVB background . This is another illustration of how genetic background can in¯uence phenotypic outcome.
Apart from retinoblastomas, IRBP-Tag mutant mice also developed brain tumors, some involving the pineal gland (al-Ubaidi et al., 1992a; Howes et al., 1994a; Marcus et al., 1996) . Similar intracranial malignancies are also seen as secondary tumors in children with hereditary retinoblastoma, a syndrome referred to as trilateral retinoblastoma (TRB) (Jakobiec et al., 1977; Bader et al., 1980; Marcus et al., 1998) . Immunohistochemical analysis of retinoblastomas in the various T antigen transgenics showed expression of neuroendocrine markers (e.g. synaptophysin) but no expression of photoreceptor cell speci®c proteins. All retinoblastomas were of highly undierentiated origin. The histopathological similarities between retinoblastomas and the brain tumors suggest that TRB arises from a germinal layer of predisposed subependymal neuroblasts not necessarily destined to become photoreceptor or pineal gland cells. The phylogenetic relationship between the pineal organ and the photoreceptors as well as IRBP expression in the pineal organ may explain the presence of these tumors in RB patients and IRBP-T antigen transgenic mice. Interestingly, Rb +/7 , p53 7/7 mice also develop pinealoblastomas, with loss of the wild-type Rb allele (Williams et al., 1994a) . It is not known whether p53 loss also plays a role in human TRB.
Due to the multitude of cellular proteins that SV40T antigen interacts with it is still unknown what all the relevant genes are in the formation of these and other tumors in mice. We have begun to dissect the mutational requirements for Rb, p107 and p53 in cancer development in mice using two dierent approaches: (1) the analysis of chimeric mice Indicated is the location of the tumors and the cell type when reported. ONL; outer nuclear layer, INL; inner nuclear layer, GCL; ganglion cell layer, PNET; primitive neuroectodermal tumor generated from ES cells lacking Rb and p107 genes (Robanus-Maandag et al., 1998); and (2) use of the Cre/LoxP and Flp/FRT systems to generate cell typespeci®c Rb knockouts (Vooijs et al., 1998) .
p107, Rb and retinoblastoma
Perhaps one of the most intriguing mouse models for retinoblastoma comes from the analysis of chimeric mice de®cient for Rb and p107. These mice develop retinoblastoma from the INL of the retina with characteristics of amacrine cells (Robanus-Maandag et al., 1998) . While Rb
, p107 7/7 de®ciency led to INL retinoblastomas in these chimeras, these mutations were not sucient to give rise to photoreceptor cell tumors from the outer nuclear layer (ONL) of the retina. Instead, Rb 7/7 , p107 7/7 cells persist in the embryonic retina but are eliminated by apoptosis after birth. Since not all animals develop retinoblastoma and those that did showed monoclonal outgrowth this indicates that additional mutations are still required. These mutations may include pathways that suppress apoptosis since abundant cell death was still observed in the retina of these mice. Apparently, the absence of p107 does not protect Rb-de®cient cells from apoptosis, but rather reduces the number of additional mutations required for transformation.
In man, inactivation of RB predisposes to retinoblastoma with nearly 100% penetrance. No involvement of p107 in retinoblastoma or any other human tumor has been reported yet (Mulligan and Jacks, 1998) . It is intriguing to speculate what the molecular basis is for this striking dierence between mouse and man. p107-de®cient mice develop normally and are not cancer prone. However, during development p107 and Rb show some functional overlap as double Rb 7/7 , p107 7/7 mutants exhibit more profound phenotypic aberrations than Rb mutant mice Mulligan and Jacks, 1998) . This compensatory eect of p107 is in line with the observation that Rb-de®cient cells show an increase in the levels of cyclin E and p107 transcription and that p107 is under direct negative repression via E2F sites in the promoter (Zhu et al., 1995b; Hurford et al., 1997) . pRb-de®cient ®broblasts show a major increase in p107/E2F complexes indicating that p107 may functionally compensate for the lack of Rb by binding E2F species normally in complex with pRb. Thus, the increase in p107/E2F complexes in Rb-de®cient cells and the direct inhibitory binding of p107 to cyclin E (A)/CDK2 complexes in late G1 (Zhu et al., 1995a; Woo et al., 1997; Castano et al., 1998) may explain how p107 restrains the growth of Rb-de®cient cells and how its loss may enhance cellular proliferation in the retina. The abundant apoptosis in the retina of these chimeric mice may result from the excess of free E2F now available to promote both cell proliferation and apoptosis (Tsai et al., 1990) . Apoptosis is likely a consequence of excess E2F1 since overexpression of other E2F family members does not lead to apoptosis but rather results in cell proliferation (Bernards, 1997; Yamasaki, 1999) .
E2F1 induced apoptosis may depend on functional p53. However, no evidence was found for the involvement of p53 in retinoblastoma from chimeric mice (Robanus-Maandag et al., 1998). There is evidence that E2F1 executes, p53-independent apoptotic pathways in Rb-de®cient cells (Agah et al., 1997; Hsieh et al., 1997; Phillips et al., 1997) . Due to the embryonic lethality of Rb/E2F1 null embryos, late stages of retinal development could not be studied (Tsai et al., 1998) ) will be instrumental in understanding the role of these genes in retinoblastoma formation in mice. Apoptosis of proliferating photoreceptors was also observed in the retinas of Rodopsin-T antigen mice. However, when Tag expressing photoreceptors were removed from the retina these cells readily proliferated in vitro and formed tumors in nude mice (al-Ubaidi et al., 1997) . The fact that photoreceptors proliferate in vitro but due in their native retinal environment suggest that paracrine signaling or limiting growth factor supply leads to apoptosis of dierentiating photoreceptor cells. Similar factors may explain the residual apoptosis seen in Rb
, p107
7/7 cells in the retina of chimeric mice (Robanus-Maandag et al., 1998) .
The importance of pocket proteins in controlling proliferation during retina development is further demonstrated by the analysis of cyclin D1-de®cient mice (Sicinski et al., 1995) . Overall, cyclin D1 knockout mice are smaller which may be a consequence of reduced pRb phosphorylation. Reduced body size is also observed in transgenic mice with constitutive pRb expression (Bignon et al., 1993) . Importantly, cyclin D1 knockouts exhibit hypoplasia of the mammary gland and the INL of the retina. One may speculate that the mouse retina, unlike the human retina is uniquely protected against loss of pRb through its family member p107. The presence of E2F binding sites in the human p107 promoter and pRB induced repression of human p107 suggests that like in mouse cells p107 may compensate for Rb loss (Zhu et al., 1995b) . However, loss of p107 has not been reported in retinoblastoma in man.
The additive eect of p107 loss in Rb mutant mice in the retina has been suggested by Lee (Lee et al., 1996 ) who found that Rb +/7 , p107 7/7 mice invariably show dysplastic lesions of the photoreceptor layer of the retina. Remarkably, these lesions occurred in the photoreceptor layer of the retina as opposed to the tumors that arose from the INL of the retina in the double Rb 7/7 , p107 7/7 chimeras. To date, the Rb status in these lesions has not been reported and therefore the importance of Rb loss in these abnormalities remains uncertain (Mulligan and Jacks, 1998) . These abnormalities never developed to tumors indicating that Rb and p107 mutations are not sucient for photoreceptor cell tumors in mice.
Tissue-speci®c Rb inactivation
The analysis of mice carrying germline mutations in tumor suppressor genes is hampered by embryonic lethality, or short lifespan due to the high incidence of speci®c tumors Ghebranious and Donehower, 1998; Hooper, 1998) . In mice carrying germline mutations in tumor suppressor genes, tumors will preferentially arise in those organs in which loss of the wild-type allele is rate limiting. This is best illustrated by the Rb and p53 mutant mice. Rb null mice are lethal while p53 null mice are viable but highly cancer prone. Although crossings between these strains has yielded important information as to how Rb and p53 pathways may synergize in cancer development, these mice primarily die from tumors attributable to p53 loss. For that reason, it has been dicult to follow disease progression of the more rare tumors in mice in which Rb loss is expected to play a role. While in some cases mice heterozygous for tumor suppressor mutations may mimic inherited cancer syndromes in man (e.g. p53 and Apc), there are many exceptions as well. These are related to species-speci®c dierences in size, life span, physiology, and genetic background. In addition, there may be a fundamental dierence between gene mutations transmitted through the germline and those that are somatically acquired. As cancer in man is primarily a sporadic disease, methods that would permit the introduction of mutations in a subset of cells in a particular tissue should mimic better the etiology of human cancer (Porter, 1999) .
Using the Cre-loxP and Flp/FRT recombination systems (Dymecki, 1996; Rajewsky et al., 1996; Meyers et al., 1998) in mice it is now possible to generate mice carrying conditional alleles of tumor suppressor genes that can be inactivated in a cell-type speci®c and timecontrolled manner (Shibata et al., 1997; Vooijs et al., 1998) . Using these recombination systems, we have generated mice carrying conditional (Floxed, FRT) alleles of multiple tumor suppressor genes including Rb (Vooijs et al., 1998) . Mice carrying loxP or FRT modi®ed Rb alleles are viable and show no cancer predisposition. However, recombinase (Cre or Flp) expression in the germ line leads to embryonic lethality similar to Rb null mice generated by conventional gene targeting.
The high incidence of pituitary tumors in Rb mutant was used to test the utility of conditional Rb inactivation in mice. Indeed, pituitary-speci®c expression of recombinase using the pro-opiomelanocortin promoter (POMC-Flp) in mice carrying conditional alleles of Rb resulted in rapid onset of intermediate lobe tumors of the pituitary gland with 100% incidence. No other abnormalities were seen in these mice. Recombination occurred eciently on both Rb alleles within the same cell and transgenic strains could be identi®ed that showed dierent rates of tumor onset and progression (Vooijs et al., 1998) .
To address the mutational requirements for Rb, p107 and p53 in tumors we have generated IRBP-Cre transgenic mice and used these mice to target Rb loss speci®cally to the photoreceptor cell compartment in the retina. The expression of IRBP in the retina starts at E13 and continues to be expressed after birth in both rod-and cone cells of the postmitotic photoreceptor layer as well as the pineal gland (al-Ubaidi et al., 1992a; Yokoyama et al., 1992) . All the cone cells are generated between E12 ± 15 of embryogenesis, while the majority of rod cells dierentiate after birth (Carter-Dawson and LaVail, 1979; Young, 1985) . IRBP-Cre; Rb/¯oxed mice were crossed with p107 and p53 mutant mice to obtain compound mutants carrying all combinations. These mice developed predominantly two types of tumors; anterior lobe tumors of the pituitary gland and pineal gland tumors (Vooijs et al., in preparation). Both tumor types were derived from cells that had undergone Cre-mediated deletion of Rb. The development of pineal gland tumors is consistent with the expression of IRBP in the pineal gland (Liou et al., 1990) . Pituitary tumors were not expected. The latter are likely a consequence of ectopic expression of the transgene. The onset of anterior lobe tumors and pineal gland tumors was accelerated in the p53-heterozygous background, and tumors showed loss of the wild-type p53 allele. Mice expressing a dominant-negative p53 allele driven by the IRBP promoter (Robanus-Mandag et al., 1998) developed similar tumors that continued to express mutant p53 (Vooijs and Berns, in preparation) . Recently, a small percentage of Rb +/7 mice were reported to develop anterior lobe tumors of the pituitary (Nikitin et al., 1999) . Pineal gland tumors also developed in Rb +/7 , p53 7/7 mice with loss of the wild-type Rb allele (Williams et al., 1994a) .
The early onset of lymphomas and sarcomas in p53-de®cient mice complicates the analysis of other tumor types in mice carrying multiple tumor suppressor gene mutations within the p53 null background. The availability of mice carrying conditional alleles of p53 will circumvent the spontaneous onset of these tumor types and permit the inactivation of p53 in a tissuespeci®c manner. p53 conditional mutant mice have been generated (J Jonkers and A Berns, unpublished) and preliminary data indicate that similar tumors develop in IRBP-Cre Rb/¯oxed, p53/¯oxed mice with Cre-mediated deletion of Rb and p53 (M Vooijs and A Berns, unpublished). These results indicate that Rb and p53 collaborate in the development of anterior lobe pituitary tumors and pineal gland tumors in mice. Interestingly the absence of p107 in these compound mice did not accelerate the onset or spectrum of tumors found. Consistent with this no loss of the p107 wild-type allele was found in these tumors. Contrary to the observation in the retina where p107 can compensate for pRb loss it is apparently incapable of doing so in other tissues.
We have found no photoreceptor cell tumors in these compound mutants. This is somewhat surprising in view of the retinoblastomas that arise in IRBP transgenic mice. We are presently investigating whether this relates to the timing of Rb inactivation. We expect that if Rb inactivation occurs postnatally in the retina that loss of Rb may not lead to tumors even in the presence of mutations in Rb, p107 and p53 (M Vooijs and A Berns, unpublished). Furthermore, it is likely that other oncogenic functions of these viral oncoproteins are contributing to the development of photoreceptor cell tumors in mice. Alternatively, the absence of tumors could relate to the genetic background of the mice in which these experiments were performed .
Conclusions
In summary, this review describes the developmental and tumorigenic consequences of an Rb mutation in mice. Using the Rb mutant mice the molecular mechanisms by which pRb controls growth, differentiation and apoptosis can be assessed in an in vivo setting. Using mouse models for Rb, species-speci®c dierences in Rb function and regulation are being uncovered. The generation of compound mutants harboring multiple tumor suppressor gene mutations permits epistatic analysis of Rb function during development as well as in tumor formation. The development of mice carrying tissue-speci®c mutations in these genes using conditional expression systems will undoubtedly further increase our understanding of the tissue-speci®c role of tumor suppressor genes. This will also permit the generation of mouse strains with speci®c tumors and establish a precise phenotypegenotype correlation. Such mouse strains are also expected to be superior for testing therapeutic intervention protocols. Finally, the derivation and establishment of isogenic cell lines from mice carrying conditional tumor suppressor gene alleles that can be inactivated at will is of great value to study a range of parameters amendable for analysis in vitro.
